Regulation 13 Exemption from charges: risks to public health
In the circumstances set out in paragraph (2), the following F1prescription items are exempt from any charge under these Regulations—
prescription items for the prevention or treatment of a condition or disease arising from an emergency that threatens, is causing or has caused serious damage or risk to public health in England or any part of England; and
prescription items, the supply of which is for, or is in anticipation of, a pandemic disease where the supply is in accordance with F2a prescription F3..., a patient group direction, a serious shortage protocol or a protocol relating to that disease as provided for in regulation 247 of the Human Medicines Regulations 2012 M1 (exemption for supply in the event or anticipation of pandemic disease).
Those circumstances are where—
the Secretary of State has made arrangements for supplying the F4prescription item to patients free of charge; or
the NHS body M2 that is responsible for the arrangements under which the prescription item is supplied has made arrangements, with the approval of the Secretary of State, for supplying the prescription item to patients free of charge,
and the patient is supplied with the prescription item under those arrangements.
Annotations
Textual amendments
- F1
Words in reg. 13(1) substituted (1.3.2021) by The National Health Service (Charges and Pharmaceutical and Local Pharmaceutical Services) (Coronavirus) (Amendment) Regulations 2021, regs. 1(2), 6(3)(a)
- F2
Words in reg. 13(1)(b) substituted (1.3.2021) by The National Health Service (Charges and Pharmaceutical and Local Pharmaceutical Services) (Coronavirus) (Amendment) Regulations 2021, regs. 1(2), 6(3)(b)
- F3
Word in reg. 13(1)(b) omitted (21.12.2021) by virtue of The National Health Service (Charges, Primary Medical Services and Pharmaceutical and Local Pharmaceutical Services) (Coronavirus) (Further Amendments) Regulations 2021 (S.I. 2021/1346), regs. 1(2)(a), 12(2)
- F4
Words in reg. 13(2) substituted (1.3.2021) by The National Health Service (Charges and Pharmaceutical and Local Pharmaceutical Services) (Coronavirus) (Amendment) Regulations 2021, regs. 1(2), 6(3)(b)
Marginal citations
- M1
S.I. 2012/1916. Regulation 247 has been amended by S.I. 2013/235.
- M2
“NHS body” is defined in section 275(1) of the National Health Service Act 2006 (c. 41).